Susanne Hafner

8PUBLICATIONS
32CO-AUTHORS
Molecular targetsMedical infection agents (incl. prions)Medicine, nursing and health curriculum and pedagogyHaematological tumoursBiologically active molecules
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Aug 29, 2024
Exploiting WEE1 Kinase Activity as FUS::DDIT3-Dependent Therapeutic Vulnerability in Myxoid Liposarcoma.

Lorena Heinst, Kwang Seok Lee, Ruth Berthold

|Oct 12, 2023
Symptoms and Management of Aseptic Liver Abscesses.

Susanne Hafner, Thomas Seufferlein, Alexander Kleger

|Mar 18, 2022
COVID-19 pandemic-related adaptations of medical education in clinical pharmacology - impact on students and lecturers at a German university.

Susanne Hafner, Oliver Zolk, Holger Barth

|Feb 17, 2022
Upregulation of Checkpoint Ligand Programmed Death-Ligand 1 in Patients with Paroxysmal Nocturnal Hemoglobinuria Explained by Proximal Complement Activation.

Markus Anliker, Daniela Drees, Lorin Loacker

|Jun 12, 2020
Chrysosplenol d, a Flavonol from Artemisia annua, Induces ERK1/2-Mediated Apoptosis in Triple Negative Human Breast Cancer Cells.

Sophia J Lang, Michael Schmiech, Susanne Hafner

|May 16, 2020
Ring-Substituted 1-Hydroxynaphthalene-2-Carboxanilides Inhibit Proliferation and Trigger Mitochondria-Mediated Apoptosis.

Tereza Kauerová, Tomáš Goněc, Josef Jampílek

Pageof 2

Frequent Collaborators

2 joint publications

Tatiana Syrovets

1 joint publications

Tomáš Goněc

1 joint publications

Josef Jampílek

1 joint publications

Ann-Kathrin Gaiser